Skip to main content

Carles Lorenzo Bosquet

Institutions of which they are part

Molecular Medical Imaging
Vall Hebron Institut de Recerca

Carles Lorenzo Bosquet

Institutions of which they are part

Molecular Medical Imaging
Vall Hebron Institut de Recerca

Projects

SGR

IP: José Raul Herance Camacho
Collaborators: Jorge Guillermo Romero Farina, Cristina Gamez Cenzano, Amparo García Burillo, Sergio Lopez Gandul, Joan Barbeta Sanchez, Manuel Escobar Amores, Ignacio Navales Mateu, Santiago Aguade Bruix, Carina Espinet Coll, Ana Maria Rodriguez Arana, Nuria Roson Gradaille, Eduard Albuixech Ginesta, Mª Carmen López Arribas, Xavier Serres Créixams, Mireia Iniesta Ambrós, Marc Simo Perdigo, Carles Lorenzo Bosquet, Carolina Aparicio Gomez, Alberto Roque Pérez, Queralt Martin Saladich, Gemma Burcet Rodríguez, Lluis Gabalda Martinez, Carmen Sanchez Suarez, Julia Baguña Torres, Esperanza Medina Gutierrez, Hug Cuellar Calabria, Daniel Eiroa Gutierrez, Irati Caballero Bermejo, Maria Teresa Veintemillas Araiz, Alvaro Jesus Valverde Moya, Maria Nazarena Pizzi, Mª Jose Moreno Negrete
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 01284
Duration: 01/01/2022 - 30/06/2025

Characterization of the CD8 T cell response in Parkinson’s disease for the development of preventive and therapeutic strategies that halt the progression of the disease: SARS-Cov-2-induced long term-hyposmia as a possible prodromal stage

IP: Jordi Bove Badell
Collaborators: Miquel Vila Bover, Alejandro Ferré Masó, Oriol de Fabregues-Boixar Nebot, Carles Lorenzo Bosquet, Thais Cuadros Arasa, Antonio Palasi Franco, David Ramos Vicente, Mariona Marchena Herrera
Funding agency: Instituto de Salud Carlos III
Funding: 165770
Reference: PI21/01358
Duration: 01/01/2022 - 31/12/2024

The Vall d’Hebron Iniciative for Parkinson associated to GBA (VHIP-GBA): from biospecimen collection to translational studies and therapies.

IP: Marta Martínez Vicente
Collaborators: José Antonio Arranz Amo, Jorge Hernández Vara, Eddie Pradas Gracia, Guillem Pintos Morell, Clara Carnicer Cáceres, Carles Lorenzo Bosquet, David Moreno Martinez, Jordi Riera Heredia, Marta Montpeyó Garcia-Moreno, Daniela Samaniego Toro, Laura Castillo Ribelles
Funding agency: Instituto de Salud Carlos III
Funding: 245932.5
Reference: PI20/00728
Duration: 01/01/2021 - 30/06/2025

Demencia mixta por Alzheimer y enfermedad cerebrovascular: un estudio clínico y experimental.

IP: Maria Pilar Delgado Martínez
Collaborators: Francesc Pujadas Navinés, Olga Maisterra Santos, Laura Castillo Ribelles, Carles Lorenzo Bosquet, Antonio Palasi Franco, Maria Belén Gutiérrez Iglesias, Jesús Pizarro Gonzálvez, Diana Liebana Gutierrez
Funding agency: Instituto de Salud Carlos III
Funding: 134310
Reference: PI19/00217
Duration: 01/01/2020 - 30/06/2024

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Phase IV AI is included in the Horizon Europe programme, lasts 3 years and prioritises data security and privacy compliance.

YSOTOPE, a DeepTech start-up with the mission to improve the use of immunotherapies through medical imaging, became part of the spin-off network of VHIR and successfully closed its first investment round of €150,000 with Biozell Ventures.

Related professionals

Alejandro  Henao  Paez

Alejandro Henao Paez

Physiology and Pathophysiology of the Digestive Tract
Read more
Amira Idrizovic

Amira Idrizovic

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Cristina Gamez Cenzano

Cristina Gamez Cenzano

Senior researcher
Molecular Medical Imaging
Read more
Camille Guillard Sirieix

Camille Guillard Sirieix

Research technician
Neurodegenerative Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.